ERBB2 and cancer: This chromatin remodelling revealed that the HNF4A and PPARGC1A regulated transcriptional regulatory networks play a pivotal role in promoting the emergence of drug resistant cancer cells and represent potential therapeutic targets to enhance the efficacy of ERBB2 inhibition strategies.